Breaking News
Get 45% Off 0
⬆ Upside Potential: Undervalued stocks with clear growth catalysts
See top stocks
Close

Fator Sinergia Fundo De Investimento Em Cotas De Fundos De Investimento Em Ações (0P0000U2R9)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
FATOR SINERGIA FUNDO DE INVESTIMENTO EM AÇÕES historical data, for real-time data please try another search
871.416 -1.020    -0.12%
27/03 - Closed. Currency in BRL
Type:  Fund
Market:  Brazil
ISIN:  BRSINCCTF002 
S/N:  13.476.201/0001-01
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: N/A
FATOR SINERGIA FUNDO DE INVESTIMENTO EM AÇÕES 871.416 -1.020 -0.12%

0P0000U2R9 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the FATOR SINERGIA FUNDO DE INVESTIMENTO EM AÇÕES (0P0000U2R9) fund. Our FATOR SINERGIA FUNDO DE INVESTIMENTO EM AÇÕES portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 6.000 6.680 0.680
Shares 93.990 93.990 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 7.170 10.304
Price to Book 1.090 1.511
Price to Sales 0.468 0.766
Price to Cash Flow 2.794 5.164
Dividend Yield 12.336 5.643
5 Years Earnings Growth 22.593 17.038

Sector Allocation

Name  Net % Category Average
Industrials 37.450 20.596
Healthcare 15.060 6.868
Real Estate 13.470 11.101
Technology 13.220 2.918
Basic Materials 11.860 15.444
Utilities 4.700 15.315
Financial Services 4.240 14.077

Region Allocation

  • Latin America
  • Emerging Markets

Top Holdings

Number of long holdings: 16

Number of short holdings: 1

Name ISIN Weight % Last Change %
CIELO SA BRCIELACNOR3 12.43 - -
  Hidrovias BRHBSAACNOR0 9.91 3.54 +2.31%
  Blau Farmaceutica BRBLAUACNOR8 9.59 14.60 +0.62%
  Sequoia BRSEQLACNOR2 7.65 1.69 -0.59%
  DIRECIONAL ON BRDIRRACNOR0 7.30 41.79 +0.41%
  RANDON PART PN BRRAPTACNPR4 6.72 9.20 -0.86%
  Simpar ON BRSIMHACNOR0 6.62 5.27 -6.23%
  CSN Mineracao BRCMINACNOR2 6.31 4.93 -0.40%
SECRETARIA TESOURO NACIONAL 6% 15/05/23 BRSTNCNTB4O9 6.13 - -
  JHSF PART ON BRJHSFACNOR2 5.36 5.30 -1.12%

Top Equity Funds by FAR Fator Admistração de Recursos Ltda

  Name Rating Total Assets YTD% 3Y% 10Y%
  FATOR ACOES FUNDO DE INVESTIMENTO E 43.12M 5.73 -5.52 6.59
  FATOR MASTER FUNDO DE INVESTIMENTO 43.19M -19.73 -4.72 8.24
  MOPYATA FUNDO DE INVESTIMENTO EM AC 3.7M 7.56 -5.36 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000U2R9 Comments

Write your thoughts about Fator Sinergia Fundo De Investimento Em Cotas De Fundos De Investimento Em Ações
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email